相似文献
1
Case-mix adjustment in non-randomised observational evaluations: the constant risk fallacy.
J Epidemiol Community Health. 2007 Nov;61(11):1010-3. doi: 10.1136/jech.2007.061747.
2
An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in Taiwan.
BMC Med. 2010 Jan 18;8:7. doi: 10.1186/1741-7015-8-7.
3
Inter-provider comparison of patient-reported outcomes: developing an adjustment to account for differences in patient case mix.
Health Econ. 2015 Jan;24(1):41-54. doi: 10.1002/hec.2999. Epub 2013 Sep 30.
4
Models used for case-mix adjustment of patient reported outcome measures (PROMs) in musculoskeletal healthcare: A systematic review of the literature.
Physiotherapy. 2019 Jun;105(2):137-146. doi: 10.1016/j.physio.2018.10.002. Epub 2018 Nov 9.
5
Development of a Medicaid behavioral health case-mix model.
Eval Rev. 2009 Dec;33(6):519-38. doi: 10.1177/0193841X09349420. Epub 2009 Oct 19.
6
Case-mix adjustment for evaluation of mortality in cystic fibrosis.
Pediatr Pulmonol. 2002 Feb;33(2):99-105. doi: 10.1002/ppul.10042.
7
Case-mix adjustment of the National CAHPS benchmarking data 1.0: a violation of model assumptions?
Health Serv Res. 2001 Jul;36(3):555-73.
8
Comparison of alternative risk adjustment measures for predictive modeling: high risk patient case finding using Taiwan's National Health Insurance claims.
BMC Health Serv Res. 2010 Dec 20;10:343. doi: 10.1186/1472-6963-10-343.
9
Regression tree boosting to adjust health care cost predictions for diagnostic mix.
Health Serv Res. 2008 Apr;43(2):755-72. doi: 10.1111/j.1475-6773.2007.00761.x.
10
Pharmacy-and diagnosis-based risk adjustment for children with Medicaid.
Med Care. 2005 Nov;43(11):1155-9. doi: 10.1097/01.mlr.0000182551.87591.73.
引用本文的文献
1
A time-adjusted control chart for monitoring surgical outcome variations.
PLoS One. 2024 May 15;19(5):e0303543. doi: 10.1371/journal.pone.0303543. eCollection 2024.
2
Comparing risk-adjusted inpatient fall rates internationally: validation of a risk-adjustment model using multicentre cross-sectional data from hospitals in Switzerland and Austria.
BMC Health Serv Res. 2024 Mar 13;24(1):331. doi: 10.1186/s12913-024-10839-x.
3
Case-mix adjustments for patient reported experience and outcome measures in primary care: an empirical approach to identify patient characteristics as case-mix adjusters based on a secondary analysis of an international survey among patients and their general practitioners in 34 countries.
J Patient Rep Outcomes. 2023 Dec 4;7(1):127. doi: 10.1186/s41687-023-00667-8.
4
Roles for Pathogen Interference in Influenza Vaccination, with Implications to Vaccine Effectiveness (VE) and Attribution of Influenza Deaths.
Infect Dis Rep. 2022 Sep 23;14(5):710-758. doi: 10.3390/idr14050076.
5
Doctors' characteristics and the use of long consultations at out-of-hours services 2008-2017: a registry-based follow-up study in Norway.
Scand J Prim Health Care. 2019 Sep;37(3):366-372. doi: 10.1080/02813432.2019.1639929. Epub 2019 Jul 11.
6
Ranking Hospitals Based on Preventable Hospital Death Rates: A Systematic Review With Implications for Both Direct Measurement and Indirect Measurement Through Standardized Mortality Rates.
Milbank Q. 2019 Mar;97(1):228-284. doi: 10.1111/1468-0009.12375.
7
Patient-reported outcome measures in arthroplasty registries Report of the Patient-Reported Outcome Measures Working Group of the International Society of Arthroplasty Registries Part II. Recommendations for selection, administration, and analysis.
Acta Orthop. 2016 Jul;87 Suppl 1(Suppl 1):9-23. doi: 10.1080/17453674.2016.1181816. Epub 2016 May 26.
8
Risk calculators-methods, development, implementation, and validation.
Int J Colorectal Dis. 2016 Jun;31(6):1111-6. doi: 10.1007/s00384-016-2589-3. Epub 2016 Apr 23.
9
Incidence and Variation of Discrepancies in Recording Chronic Conditions in Australian Hospital Administrative Data.
PLoS One. 2016 Jan 25;11(1):e0147087. doi: 10.1371/journal.pone.0147087. eCollection 2016.
10
Risk adjustment of health-care performance measures in a multinational register-based study: A pragmatic approach to a complicated topic.
SAGE Open Med. 2014 Mar 8;2:2050312114526589. doi: 10.1177/2050312114526589. eCollection 2014.
本文引用的文献
1
Use and misuse of process and outcome data in managing performance of acute medical care: avoiding institutional stigma.
Lancet. 2004 Apr 3;363(9415):1147-54. doi: 10.1016/S0140-6736(04)15901-1.
2
Evaluating non-randomised intervention studies.
Health Technol Assess. 2003;7(27):iii-x, 1-173. doi: 10.3310/hta7270.
3
Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
Health Technol Assess. 2001;5(33):1-56. doi: 10.3310/hta5330.
4
Comparison of evidence of treatment effects in randomized and nonrandomized studies.
JAMA. 2001 Aug 15;286(7):821-30. doi: 10.1001/jama.286.7.821.
5
A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.
Health Technol Assess. 2000;4(34):1-154.
6
Randomized, controlled trials, observational studies, and the hierarchy of research designs.
N Engl J Med. 2000 Jun 22;342(25):1887-92. doi: 10.1056/NEJM200006223422507.
7
A comparison of observational studies and randomized, controlled trials.
N Engl J Med. 2000 Jun 22;342(25):1878-86. doi: 10.1056/NEJM200006223422506.
8
The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials.
BMJ. 1998 Oct 31;317(7167):1185-90. doi: 10.1136/bmj.317.7167.1185.
9
Choosing between randomised and non-randomised studies: a systematic review.
Health Technol Assess. 1998;2(13):i-iv, 1-124.
10
The risks of risk adjustment.
JAMA. 1997 Nov 19;278(19):1600-7. doi: 10.1001/jama.278.19.1600.
Zotero 插件